Clinuvel Pharmaceuti
CUV
End-of-day quote AUSTRALIAN SECURITIES EXCHANGE LIMITED - 04/24
11.57AUD
-3.58%
Prev.12.0000
Open12.0000
High12.0400
Low11.5000
Volume57 258
Last news
Company
Clinuvel Pharmaceuticals Ltd. operates as a global biopharmaceutical company, which is focused on the development of SCENESSE, its proprietary photoprotective drug.It also focuses on developing drugs for the treatment of various skin disorders.The company was founded by Robert Thomas Dorr on...
Sector :
Biopharmaceuticals
Calendar :
2018-08-29 Earnings Release
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance12,012,012,3
Spread/Res.-3,6%-3,6%-5,9%
Spread/Supp.11%30%42%
Support10,58,908,15